BMRN icon

BioMarin Pharmaceuticals
BMRN

Overview Fund Activity

341 hedge funds and large institutions have $13.4B invested in BioMarin Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 58 funds opening new positions, 108 increasing their positions, 133 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
341
Holders Change
+25
Holders Change %
+7.91%
% of All Funds
9.1%
Holding in Top 10
11
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+22.22%
% of All Funds
0.29%
New
58
Increased
108
Reduced
133
Closed
27
Calls
$116M
Puts
$59M
Net Calls
+$57.3M
Net Calls Change
+$5.09M

Top Buyers

1
Victory Capital Management
Victory Capital Management
Texas
$130M
2
BBA
Baker Bros. Advisors
New York
$336M
3
TCIM
TIAA CREF Investment Management
New York
$190M
4
VAM
Visium Asset Management
New York
$89.4M
5
Fidelity Investments
Fidelity Investments
Massachusetts
$1.21B

Top Sellers

1
State Street
State Street
Massachusetts
$240M
2
Wells Fargo
Wells Fargo
California
$173M
3
AGA
Altrinsic Global Advisors
Connecticut
$64.5M
4
Alkeon Capital Management
Alkeon Capital Management
New York
$65.6M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
$6.74M
Name Holding Trade Value Shares
Change 		Shares
Change %
WMSA
151
Weiss Multi-Strategy Advisers
New York
$4.07M +$904K +10,000 +29%
SFP
152
Santa Fe Partners
New Mexico
$4.03M -$362 -4 -0%
OPPM
153
Opus Point Partners Management
New York
$3.95M +$3.95M +43,731 New
CCM
154
Cupps Capital Management
Illinois
$3.79M +$1.96M +21,713 +107%
GIBU
155
Gulf International Bank (UK)
United Kingdom
$3.75M +$217K +2,402 +6%
Susquehanna International Group
156
Susquehanna International Group
Pennsylvania
$3.67M +$2.38M +26,292 +184%
GTC
157
Ghost Tree Capital
New York
$3.62M +$3.62M +40,000 New
IGIM
158
I.G. Investment Management
Manitoba, Canada
$3.6M +$649K +7,180 +22%
BAM
159
Baring Asset Management
United Kingdom
$3.59M -$2.06M -22,769 -36%
EIM
160
Essex Investment Management
Massachusetts
$3.53M -$1.54K -17 -0%
CM
161
Castleark Management
Illinois
$3.45M +$3.45M +38,150 New
AIM
162
Assured Investment Management
New York
$3.25M -$2.24M -24,800 -41%
ABI
163
Adamant Biomedical Investments
Switzerland
$3.25M -$1.27M -14,000 -28%
IRF
164
IBM Retirement Fund
New York
$3.2M +$144K +1,588 +5%
SAM
165
Shell Asset Management
Netherlands
$3.15M +$538K +5,949 +21%
OAM
166
Oxford Asset Management
United Kingdom
$3.13M +$3.13M +33,954 New
PIM
167
Platinum Investment Management
Australia
$3.03M – – –
Credit Agricole
168
Credit Agricole
France
$2.81M +$355K +3,786 +14%
EAM
169
Eventide Asset Management
Massachusetts
$2.73M – – –
SGH
170
Sivik Global Healthcare
Connecticut
$2.69M +$886K +9,800 +49%
RJA
171
Raymond James & Associates
Florida
$2.55M +$366K +4,044 +17%
ACM
172
Arlington Capital Management
Illinois
$2.39M +$2.39M +26,439 New
CSS
173
Cubist Systematic Strategies
Connecticut
$2.37M +$2.26M +25,000 +2,083%
ST
174
Spot Trading
Illinois
$2.36M +$529K +5,848 +29%
URS
175
Utah Retirement Systems
Utah
$2.28M – – –
5 6
7
8 9